"We hope that Cannabis in Medicine special issue of EJIM will provide physicians with a contemporary summary of the different aspects related to the medical cannabis and guide the choice of an appropriate therapy for the indications where the evidence is sufficient to initiate the treatment. We hope that current issue will facilitate the conversation on the future of the medical cannabis research and its introduction into the mainstream medicine."
Edited by Victor Novack (speaker at CannX)
Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
- To access the full special issue click here.
Read the articles by our speakers in the Journal:
Medical cannabis: What physicians need to know?
Victor Novack, Head, Clinical Research Center, Soroka University Med. Center, Israel
The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report
Donald I. Abrams, Chief Hematology-Oncology, San-Francisco General Hospital, USA
Prospective analysis of safety and efficacy of medical cannabis in a large unselected population of patients with cancer
Lihi Bar-Lev Schleider, Raphael Mechoulam, Violeta Lederman, Mario Hilou, Ori Lencovsky, Oded Betzalel, Liat Shbiro, Victor Novack
Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly
Ran Abuhasira, Lihi Bar-Lev Schleider, Raphael Mechoulam
, Victor NovackContinue reading>
Is it worth investing in Israel’s medical cannabis industry in view of the regulatory fluctuations?
Read the article by Yossi Bornstein, CEO and Chair, Cann10 about the recent regulatory changes in Israel regarding the export of medical cannabis and how will this affect the investments in the field: